Dominion Energy Inc vs Revvity Inc — how do they compare? Dominion Energy Inc trades at $61.75 (market cap $54.12B), while Revvity Inc trades at $152.05 (market cap $17.14B). The key difference: Dominion Energy Inc is far larger — about 3.2× Revvity Inc's market cap, and Dominion Energy Inc pays the higher dividend (4.34%). Which is the better fit depends on your goals — on Pluang, investors hold Dominion Energy Inc for 76 Days and Revvity Inc for 12 Days on average.
| D | RVTY | |
|---|---|---|
Market Cap | $54.12B | $17.14B |
Volume | 4,249,753 | 2,226,396 |
Sector | Utilities | Health |
52-Week High | $71.67 | $157.36 |
52-Week Low | $57.08 | $82.26 |
Typical Hold Time | 76 Days | 12 Days |
Enterprise Value | $108.24B | $19.46B |
Dividend Yield | 4.34% | 0.18% |
Signals from Pluang's Aura AI — not financial advice
Dominion Energy (D) trades at $61.75, down 0.4% on the day, with technical indicators showing bearish momentum despite recent earnings beats. The company reported strong Q2 2026 EPS of $0.79 versus $0.681 expected, continuing a pattern of exceeding expectations. Fundamentals show improving revenue growth to $16.51B in 2025 and net income margin expansion to 13.99%, though cash flow trends show significant capital investments. The pending merger with NextEra Energy dominates recent news coverage, with regulators reviewing a proposed $1 billion annual Virginia supplier program.
Dominion Energy presents a mixed investment case with solid fundamental performance offset by technical weakness and merger execution risks. The stock trades below analyst consensus target of $71.56, offering potential upside if the NextEra merger proceeds smoothly. Key risks include regulatory approval uncertainty, high capital expenditure requirements, and interest rate sensitivity given the company's substantial debt load of $37.31B long-term.
RVTY trades at $153.60, up 0.2% today and near its 52-week high of $158.28. The stock shows bullish technical momentum with consistent earnings beats in recent quarters. Recent developments include the launch of a new diabetes detection kit in Europe and the acquisition of Human Cell Design to expand metabolic disease research capabilities. Operating cash flow improved to $628 million in 2026 from $583 million in 2025.
RVTY presents growth potential through diagnostic expansion and AI-driven demand, though premium valuation metrics pose near-term risks. The company faces margin pressures in China and competitive challenges. With 52% analyst buy ratings and strong institutional interest, the stock offers upside to the $165 high target but requires monitoring of Q3 earnings due November 3.
Trailing returns across standard periods
Latest headlines on both assets
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →